Skip to main content
Promino Nutritional Sciences Inc. logo

Promino Nutritional Sciences Inc. — Investor Relations & Filings

Ticker · MUSL ISIN · CA74290V2049 CSE Manufacturing
Filings indexed 217 across all filing types
Latest filing 2022-11-29 Regulatory Filings
Country CA Canada
Listing CSE MUSL

About Promino Nutritional Sciences Inc.

https://drinkpromino.com/

Promino Nutritional Sciences Inc. is a research-driven nutraceutical company specializing in the development and distribution of science-based, clinically proven nutritional products for muscle health and recovery. The company focuses on patented formulations of essential amino acids (EAAs) designed to optimize muscle protein synthesis (MPS). Its flagship product, Promino™, is a consumer supplement that delivers a precise ratio and potency of all nine EAAs, demonstrated to be significantly more effective than traditional protein sources like whey. Promino's products target athletes and individuals seeking metabolic health improvements. The company also explores clinical applications, such as retaining muscle mass in cancer patients undergoing chemotherapy.

Recent filings

Filing Released Lang Actions
52-109FV2 - Certification of interim filings - CFO (E).pdf
Regulatory Filings Classification · 100% confidence The document is a FORM 52-109FV2 Certification of Interim Filings Venture Issuer Basic Certificate signed by the CFO. It certifies the review and fair presentation of the interim financial report and interim MD&A for the period ended September 30, 2022. The document is primarily an officer certification letter and does not contain actual financial data or the interim report itself. According to the CERTIFICATION RULE, such certification documents should be classified as Regulatory Filings (RNS) rather than as the interim report (IR). The document length is short (3013 characters) and it is a certification, not the report itself.
2022-11-29 English
52-109FV2 - Certification of interim filings - CEO (E).pdf
Regulatory Filings Classification · 100% confidence The document is a certification letter titled 'FORM 52-109FV2 CERTIFICATION OF INTERIM FILINGS VENTURE ISSUER BASIC CERTIFICATE' signed by the CEO certifying the review and fair presentation of the interim financial report and interim MD&A for the period ended September 30, 2022. It explicitly states it is a certification of interim filings, not the filings themselves. The document is short (3022 characters) and primarily an officer attestation without substantive financial data or analysis. According to the Certification Rule, such documents should be classified as Regulatory Filings (RNS) rather than as an Interim Report (IR).
2022-11-29 English
Notice of the meeting and record date - English.pdf
AGM Information Classification · 95% confidence The document is a notice regarding the upcoming Annual General Meeting (AGM) of Element Nutritional Sciences Inc., specifying meeting type, record dates, meeting date, location, and voting securities details. It does not contain any financial data, management discussion, or detailed report content. The document is short (1181 characters) and serves as an announcement about the meeting and record dates rather than the AGM materials themselves. Therefore, it fits the category of AGM Information (AGM-R), which covers presentations and materials shared during the AGM or related notices about the AGM.
2022-11-21 English
News release - English.pdf
Capital/Financing Update Classification · 95% confidence The document is a press release announcing a distribution agreement and the filing of a final shelf prospectus by Element Nutritional Sciences. It does not contain financial statements or detailed financial performance data. The filing of the shelf prospectus is mentioned as a regulatory filing to maintain financial flexibility, but the document itself is an announcement rather than the prospectus or a financial report. The length is under 10,000 characters and the content is primarily an announcement of the filing and business partnership, not a detailed financial or management report. Therefore, it fits best as a Capital/Financing Update (CAP) because it relates to the filing of a shelf prospectus, which is a capital raising mechanism, and the announcement of a distribution agreement which impacts financing and business operations.
2022-08-16 English
Decision Document (Final).PDF
Regulatory Filings Classification · 95% confidence The document is a receipt from the Ontario Securities Commission for the filing of a Base Shelf Prospectus dated August 12, 2022. It is a regulatory acknowledgment of the filing rather than the prospectus itself or a detailed financial report. The document length is short (1013 characters) and it serves as a confirmation of receipt, not a report or detailed announcement. This fits the category of Regulatory Filings (RNS), which includes general regulatory announcements and compliance documents that do not fit other specific categories.
2022-08-15 English
Auditors' consent letter.pdf
Regulatory Filings Classification · 95% confidence The document is a notice regarding a change of auditor for Pangea Natural Foods Inc., submitted pursuant to National Instrument 51-102 Continuous Disclosure Obligations. It details the resignation of the former auditor and appointment of the successor auditor, with no mention of financial statements or audit results themselves. The document is short (1518 characters) and serves as an announcement rather than a full audit report or annual report. This fits the category of a Regulatory Filing (RNS) as it is a compliance disclosure about auditor change, not the audit report itself.
2022-08-12 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.